Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

ELA026, a Monoclonal Antibody Targeting Signal Regulatory Protein-α/β1/γ, Rapidly Controls Inflammation and Improves 2-Month Survival in Treatment-Naïve Malignancy-Associated Hemophagocytic Lymphohistiocytosis

Blood (2024) 144 (Supplement 1): 805.

https://doi.org/10.1182/blood-2024-204230

Published: 2024

Journal Articles

Emapalumab, a Fully Human Anti-Interferon Gamma Monoclonal Antibody, in Pediatric Patients with Primary Hemophagocytic Lymphohistiocytosis: Long-Term Follow-up of a Phase 2/3 Study

Michael B. Jordan, Carl Allen, Anupama Rao, Carmelo Rizzari, Simone Cesaro, Maria Caterina Putti, Julian Sevilla, Cristina de Min, Maria Ballabio, Veronica Asnaghi, Anna Stoltenberg, Radmila Kanceva, Franco Locatelli

Blood (2023) 142 (Supplement 1): 1174.

https://doi.org/10.1182/blood-2023-179362

Published: 2023

Journal Articles

A Global Study of Novel Agents in Paediatric and Adolescent Relapsed and Refractory B-Cell Non-Hodgkin Lymphoma (Glo-BNHL)

Blood (2023) 142 (Supplement 1): 3097.

https://doi.org/10.1182/blood-2023-178658

Published: 2023

Journal Articles

A Potential Paradigm for the Robust and Systematic Prioritisation of Assets in Academic-Led, Multi-Industry Collaborative Trials in Rare Populations (Glo-BNHL)

Blood (2023) 142 (Supplement 1): 6247.

https://doi.org/10.1182/blood-2023-178724

Published: 2023

Journal Articles

Correlation of Minimal Residual Disease (MRD) at the End of Induction (EOI) and Event Free Survival (EFS) in T-Cell Lymphoblastic Lymphoma (T-LL), a Report from the Children's Oncology Group (COG) Trial AALL1231

Blood (2022) 140 (Supplement 1): 6387–6389.

https://doi.org/10.1182/blood-2022-159694

Published: 2022

Journal Articles

Smarca4 (Brg1) Controls Germinal Center B-Cell Development and Is a Haploinsufficient Tumor Suppressor in Lymphoma

Qing Deng, Cem Meydan, Priya Lakra, Darko Barisic, Christopher R Chin, Estela Rojas-Neira, Vida Ravanmehr, Jared Henderson, Panhong Gou, Nader Kim El-Mallawany, Carl Allen, Branko Cuglievan, Francisco Vega, Christopher E Mason, Ari Melnick, Michael R Green

Blood (2022) 140 (Supplement 1): 1690–1691.

https://doi.org/10.1182/blood-2022-166258

Published: 2022

Journal Articles

Sensitivity Analysis of Overall Response Rate (ORR) with Emapalumab in Children with Primary Hemophagocytic Lymphohistiocytosis (HLH)

Franco Locatelli, MD PhD, Michael B. Jordan, MD, Carl Allen, Simone Cesaro, MD, Carmelo Rizzari, Anupama Rao, Barbara Degar, MD, Tim Garrington, MD, Julian Sevilla, MD PhD, Maria Caterina Putti, MD, Franca Fagioli, MD, Martina Ahlmann, MD, Jose-Luis Dapena Diaz, Michael Henry, MD, Fabrizio De Benedetti, MD, Alexei Grom, Anna Stoltenberg, Mårten Vågerö, Cristina de Min

Blood (2020) 136 (Supplement 1): 14–15.

https://doi.org/10.1182/blood-2020-140692

Published: 2020

Journal Articles

Safety of Emapalumab in Children with Primary Hemophagocytic Lymphohistiocytosis: Results of the Primary Analysis of the Pivotal Phase 2/3 Study

Blood (2020) 136 (Supplement 1): 24–25.

https://doi.org/10.1182/blood-2020-140766

Published: 2020

Journal Articles

Consensus recommendations for the diagnosis and clinical management of Rosai-Dorfman-Destombes disease

Oussama Abla, Eric Jacobsen, Jennifer Picarsic, Zdenka Krenova, Ronald Jaffe, Jean-Francois Emile, Benjamin H. Durham, Jorge Braier, Frédéric Charlotte, Jean Donadieu, Fleur Cohen-Aubart, Carlos Rodriguez-Galindo, Carl Allen, James A. Whitlock, Sheila Weitzman, Kenneth L. McClain, Julien Haroche, Eli L. Diamond

Blood (2018) 131 (26): 2877–2890.

https://doi.org/10.1182/blood-2018-03-839753

Published: 2018

Journal Articles

Hematopoietic origin of Langerhans cell histiocytosis and Erdheim-Chester disease in adults

Paul Milne, Venetia Bigley, Chris M. Bacon, Antoine Néel, Naomi McGovern, Simon Bomken, Muzlifah Haniffa, Eli L. Diamond, Benjamin H. Durham, Johannes Visser, David Hunt, Harsha Gunawardena, Mac Macheta, Kenneth L. McClain, Carl Allen, Omar Abdel-Wahab, Matthew Collin

Blood (2017) 130 (2): 167–175.

https://doi.org/10.1182/blood-2016-12-757823

Published: 2017

Includes: Supplemental data

Journal Articles

A Genome-Wide Assessment of Inherited Genetic Variants and the Risk of Langerhans Cell Histiocytosis

Erin Peckham, PhD, Philip J Lupo, PhD MPH, Michael E Scheurer, PhD MPH, Rikhia Chakraborty, PhD BSc, MSc, John Belmont, MDPhD, Spiridon Tsavachidis, MS, Albert Shih, BS, Harshal Abhyankar, MS, Karen Phaik Har Lim, MS, Brooks Scull, MS, Kenneth L. McClain, MD PhD, Carl Allen, MD PhD

Blood (2015) 126 (23): 4059.

https://doi.org/10.1182/blood.V126.23.4059.4059

Published: 2015

Journal Articles

Inflammatory Plasma Proteins Predict Disease Severity and Response to Therapy in Patients with LCH

Daniel Zinn, MD, Howard Lin, Albert Shih, BS, Brooks Scull, MS, Miguel Dario Cantu, Harshal Abhyankar, MS, Rikhia Chakraborty, PhD BSc, MSc, Karen Phaik Har Lim, Tricia L. Peters, MD, Sergio Lira, MD PhD, Chris Tsz-Kwong, PhD, Kenneth McClain, MD PhD, Miriam Merad, MD PhD, Carl Allen, MD PhD

Blood (2015) 126 (23): 4072.

https://doi.org/10.1182/blood.V126.23.4072.4072

Published: 2015

Journal Articles

A Novel Targeted Approach to the Treatment of Hemophagocytic Lymphohistiocytosis (HLH) with an Anti-Interferon Gamma (IFNγ) Monoclonal Antibody (mAb), NI-0501: First Results from a Pilot Phase 2 Study in Children with Primary HLH

Michael Jordan, MD, Franco Locatelli Prof, MD, PhD, Carl Allen, MD, PhD, Fabrizio De Benedetti, MD, PhD, Alexei A. Grom, Maria Ballabio, MD, Walter Giovanni Ferlin, PhD, NI-0501-04 Study Group, Cristina De Min, MD

Blood (2015) 126 (23): LBA-3.

https://doi.org/10.1182/blood.V126.23.LBA-3.LBA-3

Published: 2015

Journal Articles

Hydroxyurea for the Treatment of Relapsed/Refractory Langerhans Cell Histiocytosis

Amanda Bell Grimes, MD, Daniel Zinn, MD, Olive S. Eckstein, MD, Carl Allen, MD PhD, Kenneth McClain, MD PhD

Blood (2015) 126 (23): 1624.

https://doi.org/10.1182/blood.V126.23.1624.1624

Published: 2015

Journal Articles

Matched Unrelated Allogeneic Stem Cell Transplantation for Patients with Congenital Amegakaryocytic Thrombocytopenia: Texas Children`s Hospital Experience

Saleh Bhar, MD, Khaled Yassine, MD, Caridad Martinez, MD, Ghadir S. Sasa, MD, Swati Naik, MD, Donald Mahoney, Jr., MD, Alison A Bertuch, MD PhD, Carl Allen, MD PhD, Nabil Ahmed, MD, Meenakshi G. Hegde, MD, Helen E. Heslop, MD, Malcolm K. Brenner, MD PhD, Stephen Gottschalk, MD, Robert A. Krance, MD, Kathryn S. Leung

Blood (2015) 126 (23): 5529.

https://doi.org/10.1182/blood.V126.23.5529.5529

Published: 2015

Journal Articles

Allogeneic Stem Cell Transplantation in a Pediatric Patient with Whim Syndrome

Saleh Bhar, MD, Khaled Yassine, MD, Caridad Martinez, MD, Ghadir S. Sasa, MD, Swati Naik, MD, Donald Mahoney, Jr., MD, Carl Allen, MD PhD, Nabil Ahmed, MD, Meenakshi G. Hegde, MD, Helen E. Heslop, MD, Stephen Gottschalk, MD, Robert A. Krance, MD, Kathryn S. Leung

Blood (2015) 126 (23): 5528.

https://doi.org/10.1182/blood.V126.23.5528.5528

Published: 2015

Journal Articles

The evolution of cellular deficiency in GATA2 mutation

Blood (2014) 123 (6): 863–874.

https://doi.org/10.1182/blood-2013-07-517151

Published: 2014

Includes: Supplemental data

NARROW

ELA026, a Monoclonal Antibody Targeting Signal Regulatory Protein-α/β1/γ, Rapidly Controls Inflammation and Improves 2-Month Survival in Treatment-Naïve Malignancy-Associated Hemophagocytic Lymphohistiocytosis

Emapalumab, a Fully Human Anti-Interferon Gamma Monoclonal Antibody, in Pediatric Patients with Primary Hemophagocytic Lymphohistiocytosis: Long-Term Follow-up of a Phase 2/3 Study

A Global Study of Novel Agents in Paediatric and Adolescent Relapsed and Refractory B-Cell Non-Hodgkin Lymphoma (Glo-BNHL)

A Potential Paradigm for the Robust and Systematic Prioritisation of Assets in Academic-Led, Multi-Industry Collaborative Trials in Rare Populations (Glo-BNHL)

Correlation of Minimal Residual Disease (MRD) at the End of Induction (EOI) and Event Free Survival (EFS) in T-Cell Lymphoblastic Lymphoma (T-LL), a Report from the Children's Oncology Group (COG) Trial AALL1231

Smarca4 (Brg1) Controls Germinal Center B-Cell Development and Is a Haploinsufficient Tumor Suppressor in Lymphoma

Sensitivity Analysis of Overall Response Rate (ORR) with Emapalumab in Children with Primary Hemophagocytic Lymphohistiocytosis (HLH)

Safety of Emapalumab in Children with Primary Hemophagocytic Lymphohistiocytosis: Results of the Primary Analysis of the Pivotal Phase 2/3 Study

Consensus recommendations for the diagnosis and clinical management of Rosai-Dorfman-Destombes disease

Hematopoietic origin of Langerhans cell histiocytosis and Erdheim-Chester disease in adults

A Genome-Wide Assessment of Inherited Genetic Variants and the Risk of Langerhans Cell Histiocytosis

Inflammatory Plasma Proteins Predict Disease Severity and Response to Therapy in Patients with LCH

A Novel Targeted Approach to the Treatment of Hemophagocytic Lymphohistiocytosis (HLH) with an Anti-Interferon Gamma (IFNγ) Monoclonal Antibody (mAb), NI-0501: First Results from a Pilot Phase 2 Study in Children with Primary HLH

Hydroxyurea for the Treatment of Relapsed/Refractory Langerhans Cell Histiocytosis

Matched Unrelated Allogeneic Stem Cell Transplantation for Patients with Congenital Amegakaryocytic Thrombocytopenia: Texas Children`s Hospital Experience

Allogeneic Stem Cell Transplantation in a Pediatric Patient with Whim Syndrome

The evolution of cellular deficiency in GATA2 mutation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only